Abiopharma

🔍 Whitehead Michael J (Director)

Company: MATTHEWS INTERNATIONAL CORP (MATW)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 69,198 shares of Restricted Share Units (Derivative)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 69,198.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F3

Footnotes:

• F1: Award of restricted share units under the Company's Amended and Restated 2017 Equity Incentive Plan (the "Plan"), subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive shares of the Company's common stock as described below.
• F2: The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $23.12, which represents the average of the high and low trading prices per share of the Issuer's Class A common stock on the Nasdaq Global Select Market for the 20 days of trading that immediately preceded the date of issuance.
• F3: The award is expected to vest on August 31, 2027 subject to the Reporting Person's continued service to the Issuer through such date, at which point the restricted share units will be converted to an equal number of shares of the Issuer's Class A common stock.
• REMARKS: The Power of Attorney dated August 31, 2026 was filed on August 31, 2026, in Form 3, and is incorporated herein by reference.